NOTE 2 ACQUISITIONS 2013 Acquisitions During the nine months ended September 30, 2013, the Corporation acquired a business for a total purchase price of $4.1 million. The resulting amount of goodwill related to this transaction was $2.2 million. 2012 Acquisitions Amerita Acquisition On December 13, 2012 the Corporation, through a wholly-owned subsidiary, acquired all of the outstanding stock of Amerita, Inc., a Delaware corporation ( Amerita ), for $84.5 million, net of cash acquired of $1.0 million, including the working capital adjustment in the first quarter of 2013. During the nine months ended September 30, 2013, the final working capital adjustment was completed for the Amerita acquisition resulting in additional purchase price paid of $0.5 million. The Corporation s primary purpose in acquiring Amerita, Inc. was to complement existing pharmacy services through the provision of additional infusion services. The total purchase price of Amerita was allocated to the net tangible and identifiable intangible assets based upon their fair values on December 13, 2012. The excess of the purchase price over the fair values of the net tangible and identifiable intangible assets was recorded as goodwill. The Corporation believes the resulting amount of goodwill reflects its expectation of the synergistic benefits of the acquisition. For tax purposes, the transaction was considered a stock acquisition. Approximately $14.5 million of goodwill related to previous acquisitions made by Amerita will be tax deductible by the Corporation. The preliminary allocation of the purchase price was based upon the fair value of net tangible and identifiable intangible assets as of December 13, 2012. The preliminary purchase price allocation was as follows (dollars in millions): Amounts Previously Recognized as of Acquisition Date (1) Measurement Period Adjustments Amounts Recognized as of Acquisition Date (As Adjusted) Accounts receivable $ 11.1 $ (1.1 ) $ 10.0 Inventory 1.6 - 1.6 Other current assets 0.6 0.2 0.8 Equipment and leasehol